semaglutide approved for cardiovascular FDA approves weight-loss drug Wegovy to reduce heart-disease risks Appetite Control and Suppressants size:1.7mg Virgie - Marketing is

semaglutide approved for cardiovascular FDA approves weight-loss drug Wegovy to reduce heart-disease risks Appetite Control and Suppressants size:1.7mg Virgie - Marketing is

Virgie - Marketing is not medicine. This 👆🏾 is an example of what I mean. GLP-1 manufacturers are not above the FDA. So why is their marketing for a weight-loss drug that

adults, with annual treatment costs climbing sharply across health systems

Appetite Control and Suppressants

size:1.7mg

Piper Sandler analysts said in a note that Hims should be fine "for the time being." They noted, however, that the FDA's move does signal that it's "not giving much leeway for the compounders."